Unitaid

03/09/2026

What will it take to make twice-yearly HIV prevention accessible?

In Brazil, the Unitaid-funded ImPrEP LEN study is exploring how people choose, access and use lenacapavir.

In this video, Dr Beatriz Grinsztejn shares what it could take to turn the promise of this new prevention option into real-world impact.

Find out more: https://ow.ly/wAXk50ZI9L1

02/09/2026

Innovation is only the beginning.

As countries prepare to introduce a new generation of malaria prevention, we are investing US$36 million to generate the evidence needed to support effective rollout.

From spatial emanators to insecticide-treated baby wraps, the research will help turn promising innovations into greater impact against malaria.

Read more: https://ow.ly/V73350ZI8R5

31/08/2026

Every day, over 700 women die from preventable causes related to pregnancy and childbirth.

One of the main causes is postpartum hemorrhage, which can become fatal within hours if not treated.

But in countries like Kenya and Nigeria, new tools and approaches are helping health workers detect bleeding earlier and respond faster.

In some settings, this has contributed to a 75% reduction in deaths.

When mothers survive, the impact extends far beyond the delivery room.

28/08/2026

Behind every statistic is a person.

A woman screened for cervical cancer close to home.

A child receiving medicines designed for children.

A family protected from malaria.

A mother surviving childbirth.

For 20 years, we have worked to help ensure health innovations reach the people who need them.

Because access is measured not only in products delivered, but in lives changed.

27/08/2026

How do we make access to innovation truly equitable?

As we celebrate 20 years of Unitaid, we’re bringing together voices from across the global health community to reflect on the future of health innovation — and what it will take to ensure its benefits reach everyone, everywhere.

In this video, Abdul-Fatawu Salifu, a young leader and public health advocate from Ghana, and Dr. Michael Charles, CEO of the RBM Partnership to End Malaria, share their perspectives on equitable access to innovation and the importance of ensuring new advances can reach the communities that need them.

26/08/2026

20 years of turning innovation into impact.

From breakthrough ideas to real-world change, our journey has always been about making health innovations accessible.

Hear from Unitaid's Executive Director, Philippe Duneton on our journey and what comes next.

Modelling from the Global Fund shows that health innovations – like those supported by Unitaid – can fast-track responses by up to three years.

25/08/2026

A new article in The Independent, authored by Molly Thompson of STOPAIDS looks at the global access challenge around lenacapavir, as the twice-yearly HIV prevention injection becomes available in England, while it remains out of reach for millions of people in low- and middle-income countries.

Lenacapavir has the potential to transform HIV prevention, offering a new option for people who face barriers to taking a daily pill.

Unitaid has helped support a pathway to generic lenacapavir at around US$40 per person per year across 120 low- and middle-income countries.

Now, the focus is on making sure this innovation can reach the people who can benefit from it.

Read the full article in The Independent: https://www.independent.co.uk/news/health/hiv-nhs-drug-lenacapavir-england-africa-b3036427.html

Game-changing HIV drug Lenacapavir will soon be saving lives across the country, writes Molly Thompson, yet marginalised communities in the global south who made this possible still don’t have access

21/08/2026

What will the future of health innovation look like?

To mark our 20th anniversary, we’re bringing together voices from across the global health community to share their ideas, innovations and hopes for the future.

In this video, Deborah Waterhouse, Dr. Mark Dybul and Charles Gore reflect on what we’ve learned about innovation and access, and what it will take to make sure new discoveries can reach the people and communities who can benefit from them.

As we look ahead to the next 20 years:

Innovation creates possibility. Access creates impact.

20/08/2026

Malaria continues to have a devastating impact across many countries, particularly in Africa, which accounts for around 95% of global deaths.

A child still dies from malaria every minute.

But progress is being made through new and improved tools, from prevention to treatment.

The challenge now is ensuring these tools reach everyone who needs them.

19/08/2026

Twenty years ago, malaria programs relied on a far smaller set of tools.

Today, countries have access to a growing toolbox that includes next-generation mosquito nets, new prevention approaches, vaccines, improved diagnostics and innovative vector control strategies.

This evolution matters because malaria is evolving too.

Sustaining progress depends on continuing to expand the range of tools available to communities and health systems.